Tapering/Discontinuing Biologics

Estándar

Hi friends, on these days I’m in Brazil visiting my colleagues of this beautiful country. One of the principal purposes of this trip is to discuss with them the important issue of tapering (or discontinuing) biologics in rheumatic conditions, once the patient has achieved a good clinical status (remission or low disease activity). There is a lot of evidence, but unfortunately, many studies have been conducted in patients (that in our clinical setting) they shouldn’t be candidates to receive biologics. Nonetheless, after an extensive review, I could achieve some conclusions that I intend to share with you once my visit has ended. Then, it will be great getting your feedback. Now as a starter, I attach the outline of my presentation. Cheers…

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )

w

Conectando a %s